查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
自訂抗體的到市場規模，佔有率，趨勢分析:各類型，各類服務，各原料，各研究領域，各終端用戶，各地區展望，競爭策略，至2030年的各市場區隔預測
市場調查報告書
商品編碼
1070364

自訂抗體的到市場規模，佔有率，趨勢分析:各類型，各類服務，各原料，各研究領域，各終端用戶，各地區展望，競爭策略，至2030年的各市場區隔預測

Custom Antibody Market Size, Share & Trends Analysis By Type, By Service, By Source, By Research Area, By End-User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 228 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球自訂抗體的市場規模，預計今後以9.4％的年複合成長率擴大，至2030年達到8億8,960萬美元。產學聯合增加，生命科學產業為中心的研究活動的活躍，是市場擴大的原動力。

本報告提供全球自訂抗體市場相關調查，市場概要，以及各類型，各類服務，各原料，各研究領域，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 成長要素，阻礙因素，機會，課題的分析
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 自訂抗體市場的COVID-19影響

第5章 市場變數及預測

  • SWOT分析
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • PESTEL分析
    • 政治形勢
    • 經濟形勢
    • 社會形勢
    • 技術形勢
    • 環境形勢
    • 法律上的形勢
  • 波特的五力分析
    • 賣主談判力
    • 買方議價能力
    • 替代威脅
    • 新加入廠商的威脅
    • 競爭企業間的敵對關係
  • 熱圖分析

第6章 全球自訂抗體市場，各類型，2019年～2030年(100萬美元)

  • 單株抗體
  • 其他的自訂抗體
  • 多株抗體
  • 重組抗體

第7章 全球自訂抗體市場，各類服務，2019年～2030年(100萬美元)

  • 抗體開發
  • 抗體的生產與精製
  • 抗體的片斷化和標記

第8章 全球自訂抗體市場，各原料，2019年～2030年(100萬美元)

  • 鼠
  • 兔
  • 其他

第9章 全球自訂抗體市場，各研究領域，2019年～2030年(100萬美元)

  • 循環系統疾病
  • 免疫學
  • 感染疾病
  • 神經生物學
  • 腫瘤學
  • 其他
  • 幹細胞

第10章 全球自訂抗體市場，各終端用戶，2019年～2030年(100萬美元)

  • 學術研究
  • CRO
  • 製藥公司，生物科技企業

第11章 全球自訂抗體市場，各地區，2019年～2030年(100萬美元)

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 中東、非洲
    • 沙烏地阿拉伯王國
    • 阿拉伯聯合大公國
    • 其他

第12章 企業簡介

  • BioLegend
  • Bio-Rad Laboratories, Inc
  • Cell Signaling Technology, Inc.
  • GenScript
  • Merck Group
  • Rockland Immunochemicals
  • Thermo Fisher Scientific, Inc
簡介目錄
Product Code: BIOT2214

Global Custom Antibody Market projected to be worth USD 889.6 million by 2030.

According to SPER Market Research, the Custom Antibody Market estimated to reach USD 889.6 million by 2030 with a CAGR of 9.4%.

Increasing industry-academia collaborations, growing research activity particularly in the life sciences industry; are the key that impel the market expansion.

Impact of COVID-19 on the Custom Antibody Market

Increase in research activities, availability of funding for research and the demand for antibodies, pharmaceutical companies, and small start-ups, has taken step to develop treatments and vaccines that target the infection. So there is a positive impact in this custom antibody market.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered By Type, By Service, By Source, By Research Area, By End-User, By Region

  • Geographies covered : North America, Europe, Asia Pacific, Latin America, Middle East, Africa
  • Companies Covered: BioLegend, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., GenScript, Merck Group, Rockland Immunochemicals, Thermo Fisher Scientific, Inc.

Driver: growing research activities and funding

Growing research activities and funding, quality concerns over catalogue antibodies, increasing industry-academia collaborations, rising focus on therapeutic antibodies and extensive pipeline drugs; are the key factors that drive the market expansion.

Restraint:

Antibody development is a costly and time consuming process that resists the market expansion.

Opportunity: Increasing demand for personalized medicine in protein therapeutics

Growing demand for personalized medicine in protein therapeutics, rising focus on biomarker discovery, high growth opportunities in developing countries.

Challenges: Presence of Alternative Antibodies

Availability of alternative antibodies in the market that is a challenge to the custom antibody market expansion.

Global Custom Antibody Market, By Type:

Based on the Type, Global Custom Antibody Market is segmented as; Monoclonal Antibodies, Other Custom Antibodies, Polyclonal Antibodies, Recombinant Antibodies.

Global Custom Antibody Market, By Service:

Based on the Service, Global Custom Antibody Market is segmented as; Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling.

Global Custom Antibody Market, By Source:

Based on the Source, Global Custom Antibody Market is segmented as; Mice, Rabbits, Other Sources.

Global Custom Antibody Market, By Research Area:

Based on the Research Area, Global Custom Antibody Market is segmented as; Cardiovascular Disease, Immunology, Infectious Diseases, Neurobiology, Oncology, Other Research Areas, Stem Cells.

Global Custom Antibody Market, By End-User:

Based on the End-User, Global Custom Antibody Market is segmented as; Academic & Research Institutes, Contract Research organizations, Pharmaceutical & Biotechnology Companies.

Global Custom Antibody Market, By Region:

North America owns the biggest share of the Global Custom Antibody Market; this is because of increasing research in the fields of genomics and proteomics, antibody-based therapeutics. The growing investments in the development of structure-based drug designs, and growing demand for high-quality research tools for data reproducibility.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Custom Antibody Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Custom Antibody Market, By Type, 2019-2030 (USD Million)

  • 6.1. Monoclonal Antibodies
  • 6.2. Other Custom Antibodies
  • 6.3. Polyclonal Antibodies
  • 6.4. Recombinant Antibodies

7. Global Custom Antibody Market, By Service, 2019-2030 (USD Million)

  • 7.1. Antibody Development
  • 7.2. Antibody Production & Purification
  • 7.3. Antibody Fragmentation & Labeling

8. Global Custom Antibody Market, By Source, 2019-2030 (USD Million)

  • 8.1. Mice
  • 8.2. Rabbits
  • 8.3. Other Sources

9. Global Custom Antibody Market, By Research Area, 2019-2030 (USD Million)

  • 9.1. Cardiovascular Disease
  • 9.2. Immunology
  • 9.3. Infectious Diseases
  • 9.4. Neurobiology
  • 9.5. Oncology
  • 9.6. Other Research Areas
  • 9.7. Stem Cells

10. Global Custom Antibody Market, By End-User, 2019-2030 (USD Million)

  • 10.1. Academic & Research Institutes
  • 10.2. Contract Research organizations
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Global Custom Antibody Market, By Region, 2019-2030 (USD Million)

  • 11.1. North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5. Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

12. 1. BioLegend

    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Bio-Rad Laboratories, Inc.
  • 12.3. Cell Signaling Technology, Inc.
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. GenScript
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments

12. 5. Merck Group

    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments

12. 6. Rockland Immunochemicals

    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments

12. 7. Thermo Fisher Scientific, Inc

    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments